Work

Validation of rano criteria: Contribution of T2/FLAIR assessment in patients with recurrent glioblastoma treated with bevacizumab.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2007

Authors: Raymond Yi-kun Huang, Rifaquat Rahman, Whitney B. Pope, Benjamin M. Ellingson, S. Keith Anderson, Sara J Felten, Karla V. Ballman, Wenting Wu, Lakshmi Nayak, Eudocia Quant Lee, Lauren E. Abrey, Evanthia Galanis, David A. Reardon, Timothy Francis Cloughesy, Patrick Y. Wen

Institutions: Brigham and Women's Hospital, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Harvard University, University of California, Los Angeles, Mayo Clinic, Roche (Switzerland)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2603876887

Cites:

Cited by: 6

Related to: 10